2.4.0.8122 - Disclosure - STOCK-BASED COMPENSATION (Details)truefalsefalse1false USDfalsefalse$P04_01_2013To06_30_2013http://www.sec.gov/CIK0001333763duration2013-04-01T00:00:002013-06-30T00:00:00sharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USD_per_ShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2false USDfalsefalse$P04_01_2012To06_30_2012http://www.sec.gov/CIK0001333763duration2012-04-01T00:00:002012-06-30T00:00:00sharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USD_per_ShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$3false USDfalsefalse$P01_01_2013To06_30_2013http://www.sec.gov/CIK0001333763duration2013-01-01T00:00:002013-06-30T00:00:00sharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USD_per_ShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$4false USDfalsefalse$P01_01_2012To06_30_2012http://www.sec.gov/CIK0001333763duration2012-01-01T00:00:002012-06-30T00:00:00sharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USD_per_ShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$1false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse200000200000falsefalsefalse2falsefalsefalse00  falsefalsefalse3truefalsefalse985500985500falsefalsefalse4truefalsefalse13090001309000falsefalsefalsexbrli:sharesItemTypesharesNet number of share options (or share units) granted during the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false1Options granted during period (in shares)2false 4us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalsedefinitionGuidance1truefalsefalse1.771.77USD$falsetruefalse2falsefalsefalse00  falsefalsefalse3truefalsefalse1.101.10USD$falsetruefalse4truefalsefalse4.604.60USD$falsetruefalsenum:perShareItemTypedecimalWeighted average per share amount at which grantees can acquire shares of common stock by exercise of options.No definition available.false3Weighted average exercise price (in dollars per share)3false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse1.011.01USD$falsetruefalse2falsefalsefalse00  falsefalsefalse3truefalsefalse0.770.77USD$falsetruefalse4truefalsefalse3.093.09USD$falsetruefalsenum:perShareItemTypedecimalThe weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false3Weighted average grant date fair value (in dollars per share)falseSTOCK-BASED COMPENSATION (Details) (USD $)UnKnownNoRoundingNoRoundingUnKnowntruefalsefalseSheethttp://www.chelseatherapeutics.com/role/StockbasedCompensationDetails43